Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer.
Thoen H, Ceelen W, Boterberg T, Van Daele E, Pattyn P.
Radiother Oncol. 2015 Apr;115(1):16-21. doi: 10.1016/j.radonc.2015.03.012. Epub 2015 Mar 25.
PMID:25818394
The role of tumor microenvironment and exosomes in dormancy and relapse.
Attaran S, Bissell MJ.
Semin Cancer Biol. 2022 Jan;78:35-44. doi: 10.1016/j.semcancer.2021.09.008. Epub 2021 Oct 30.
PMID:34757184
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Campagne O, Banerjee A, Gururangan S, Kilburn LB, Goldman S, Qaddoumi I, Baxter P, Vezina G, Bregman C, Patay Z, Jones JY, Stewart CF, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.
Neuro Oncol. 2021 Oct 1;23(10):1777-1788. doi: 10.1093/neuonc/noab047.